Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. (Q37372837)
Jump to navigation
Jump to search
scientific article published on 22 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. |
scientific article published on 22 June 2009 |
Statements
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies (English)
Tamer E Fandy
James G Herman
Patrick Kerns
Anchalee Jiemjit
Elizabeth A Sugar
Si-Ho Choi
Allen S Yang
Timothy Aucott
Tianna Dauses
Rosalie Odchimar-Reissig
Jonathan Licht
Chris Nasrallah
Marianne K H Kim
Weijia Zhang
Yezou Sun
Anthony Murgo
Igor Espinoza-Delgado
Katharine Oteiza
Ibitayo Owoeye
Lewis R Silverman
Steven D Gore
Hetty E Carraway
22 June 2009
1 reference
1 reference
1 reference
1 reference
1 reference